English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 産科/婦人科:機会インデックス
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

産科/婦人科:機会インデックス

Obstetrics and Gynecology: The Opportunity Index

発行 Valid Results, Inc
出版日 2008年04月 商品コード 64843
ページ情報 英文  
価格
US$ 7,500 換算 ¥ 604,275 (税抜) PDF By E-mail (Single User License)
US$ 10,000 換算 ¥ 805,699 (税抜) PDF By E-mail (Global Site License)


原文目次

Abstract

100 AMA-member (American Medical Association) Ob/Gyn respondents were randomly selected from a list of over 24,000 Ob/Gyns to participate in a self-administered questionnaire (SAQ) featured on the internet.

The purpose of the study is to develop an overview of the perceived positioning of 21 featured medical device and 16 pharmaceutical companies, as well as the considerations associated with determining a company' s position.

The results feature a summary of Ob/Gyn surgeons' perceptions on the importance of specific considerations in evaluating manufacturers. Each featured company is positioned based on their performance on the considerations. The analysis includes a multivariate metric to compare the relative positioning of competing manufacturers. Also included is a positioning of competitive manufacturers based on the perceived strength of association with listed qualities.

The results of the data analysis indicate there are several of leading companies currently servicing Ob/Gyns. Among the device companies, Ethicon' s performance is perceived to be highest on all considerations. Berlex Laboratories is perceived to perform highest on 7 of 10 considerations, relative to the featured pharmaceutical companies.

The information has applicability to advertising, sales, communications, product launches, forecasting, and strategic planning, as well as other business functions.

Table of Contents

Introduction & Report Overview

  • Abstract
  • Measurement Objectives
  • Sample design and distribution/Measurement and Date Collection Design
  • How to read this report

Executive Summary & Key Findings

Detailed Findings

I. Importance

  • a. Important considerations influencing product preferences
  • b. Ratings of importance considerations

II. Awareness & Associations

  • a. Awareness and experience with featured medical device manufacturers
  • b. Awareness and experience with featured pharmaceutical companies
  • c. Top of mind products for featured manufacturers
  • d. Top of mind manufacturer for featured considerations

III. Performance

  • a. “Best” overall company
  • b. “Worst” overall company
  • c. Medical Device Manufacturer - Performance ratings
  • d. Medical Device Standardized by Column/Consideration
  • e. Medical Device Standardized by Row/Manufacturer
  • f. Medical Device Companies Importance/Performance Gap
  • g. Medical Device Positioning on Importance/Performance Rating
  • h. Pharmaceutical Companies-Performance ratings
  • i. Pharmaceutical Standardized by Column/Consideration
  • j. Pharmaceutical Standardized by Row/Manufacturer
  • k. Pharmaceutical Companies Importance/Performance Gap
  • l. Pharmaceutical Companies' Positioning on Importance/Performance Rating

Suggested Additional Analysis

About the Author / Valid Results

Back to Top